Blueprint Medicines Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	46.56	46.16	66.42	55.9	41.31	32
Other Amortization	1.78	1.68	1.43	1.46	1.38	1.73
Loss (Gain) From Sale of Investments	-0.7	-0.96	-1.19	1.01	12.73	18.95
Asset Writedown & Restructuring Costs	-1.5	-1.5	-0.06	0.36	4.37	-
Provision for Credit Losses	16.78	16.13	3.65	7.48	1.66	2.99
Change in Accounts Payable	-0.5	1.4	0.24	0.02	-0.3	-0.08
Change in Unearned Revenue	1.02	1.83	-3.5	0.76	0.25	-1.73
Change in Other Net Operating Assets	-76.18	-102.47	206.31	-1.31	0.97	1.5
Other Operating Activities	-34.89	-30.93	-13.5	17.48	19.24	24.02
Operating Cash Flow	-47.77	-69.08	259.46	83.17	81.61	79.39
Operating Cash Flow Growth	-	-	211.96%	1.91%	2.80%	-22.56%
Investment in Securities	-	-	-3	1.26	1.56	-13.22
Net Decrease (Increase) in Loans Originated / Sold - Investing	-	-	-	-53.05	-23.25	74.07
Other Investing Activities	4.08	2.19	0.43	0.09	0.88	-0.16
Investing Cash Flow	67.94	1.66	-2.51	-44.18	-21.38	60.18
Long-Term Debt Issued	-	183	-	31	96.57	-
Total Debt Issued	148	183	-	31	96.57	-
Long-Term Debt Repaid	-	-45	-191	-	-84.82	-47.98
Net Debt Issued (Repaid)	38	138	-191	31	11.75	-47.98
Issuance of Common Stock	-	-	-	14.08	7.28	-
Repurchase of Common Stock	-7.31	-5.88	-12.18	-3.69	-0.42	-23.59
Common Dividends Paid	-51.45	-56.17	-51.73	-52.22	-51.25	-51.89
Other Financing Activities	-	-	-	-31.62	-21.53	-24.58
Financing Cash Flow	-20.76	75.95	-254.91	-42.45	-54.18	-148.04
Foreign Exchange Rate Adjustments	-0	-0.03	-0.07	-0.05	-0.14	-0.09
Net Cash Flow	-0.59	8.5	1.97	-3.51	5.92	-8.56
Cash Interest Paid	33.64	32.34	36.48	31.62	21.53	24.58

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.